The original paper is in Mandarin and you can access it here (paywall): #Type2Diabetes #DiabetesResearch #Obesity #GLP1 #Semaglutide #Dorzagliatin #MetabolicHealth #HuaMedicine To view or add a comment, sign in A newly published peer-reviewed scientific paper from China adds to the growing body of evidence around the benefits that dorzagliatin (GKA) in combination with the popular semaglutide (GLP-1RA) delivers superior glycemic control, weight reduction, and islet cell function improvement when compared with semaglutide monotherapy in obese patients with Type 2 diabetes mellitus (T2DM), with a comparable safety profile
Key Features Advanced TriNA Pico-Cell cosmetic formulation Contains Queto-Glutathione as a key cosmetic ingredient Multi-vial system: liquid + lyophilized powder Includes peptides, vitamins, antioxidants, and botanical extracts Developed under Swiss laboratory collaboration Designed for professional cosmetic and aesthetic skincare routines Cosmetic Benefits When used as part of a professional cosmetic skincare routine, Aqua Skin Veniscy 999 TriNA Pico-Cell is commonly associated with: Brighter-looking and more refreshed skin appearance Support for even-looking skin tone Improved skin clarity and radiance Enhanced overall skin appearance over time Cosmetic results may vary depending on individual skin type, routine, and lifestyle
Structural and thermodynamic consequences of base pairs containing pseudouridine and N1-methylpseudouridine in RNA duplexes
Allergens: The product does not contain common allergens but may be manufactured in a facility processing nuts and sesame
